Just recently, Cetaphil - the world’s #1 dermatologist-recommended skin care brand - has announced the launch of its latest campaign, which focuses on giving women the opportunity to improve their skin confidence.
Dubbed as 'Cetaphil Experience' the campaign is run on social media and is designed for women to express what skin confidence means to them. The campaign aims to give women a chance to celebrate and see how they can enjoy themselves and learn from the experts on how to balance the day-to-day demands on their skin.
|The Cetaphil Experience.|
Contestants can join the competition by registering through the Cetaphil Experience app in Cetaphil Philippines Facebook page. Every contestant that takes a stab at the grand prize also has the chance of winning a Cetaphil Gentle Skin Cleanser!
For more information, visit Cetaphil Philippines on Facebook http://bit.ly/1IBUGuT
Cetaphil range of cleansers, moisturizers and sun protection products belong to the Cetaphil family of skincare solutions developed for use by dermatologists worldwide for over 40 years. During this period, Cetaphil has received numerous awards and seals of approval from beauty insiders and the healthcare community.
Cetaphil shares a well-established medical heritage. The iconic Cetaphil Gentle Skin Cleanser was originally founded by a pharmacist in 1947 as a compounding vehicle for dermatological remedies. It was the first skincare product formulated by dermatologists as a stand-alone skin care product gentle enough for all skin types.
Today, about one bottle is sold every minute across the globe and its formula developed in 1947 still holds true to tradition, without change – even to this day.
Galderma is a global company founded in 1981, committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 34 wholly-owned affiliates with a worldwide network of distributors and more than 5,000 employees.
Galderma’s extensive product portfolio is available in 80 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis and steroid-responsive dermatoses, pigmentary disorders, skin cancer, and medical solutions for skin senescence.